Institutul National de Diabet, Nutritie si Boli Metabolice "N.C. Paulescu"

At the Institutul National de Diabet, Nutritie si Boli Metabolice "N.C. Paulescu" in Bucuresti, most studies focus on Nutritional and Metabolic Diseases, especially Type 2 Diabetes and related problems such as poor glycaemic control and excess body weight. The trials are designed to test new treatment options, compare them with established therapies, and improve everyday diabetes management.

• Evaluating new therapies to improve blood sugar control in people with Type 2 Diabetes Mellitus
• Comparing treatment approaches for diabetes that is not well controlled with standard care
• Studying the combined impact of glucose-lowering and weight-related treatments

This work reflects a strong clinical focus on helping patients achieve better long-term metabolic control while also addressing broader health risks linked to diabetes.

Another major area of research at this site is Cardiovascular Diseases, with trials centered on atherosclerotic cardiovascular disease, heart failure, hypertension, and related risk reduction. These studies aim to determine whether newer therapies can lower the chance of serious heart and vascular events in people already at high risk.

• Testing treatments for ASCVD and primary prevention of cardiovascular events
• Assessing strategies to reduce the risk of heart failure and cardiovascular death
• Studying therapies for patients with elevated Lp(a) and other major risk factors

The site’s cardiovascular portfolio emphasizes prevention, long-term outcomes, and improving protection for patients with complex cardiometabolic disease.

Research here also addresses complications linked to diabetes, including diabetic retinopathy and cardiovascular risk in people with other chronic conditions such as ESKD. These trials are exploring whether treatment can help protect organs beyond glucose lowering alone.

• Studying eye disease progression in people with Type 2 Diabetes
• Evaluating inflammation and cardiovascular risk in patients with advanced kidney disease
• Exploring broader safety and long-term benefit of therapies used in chronic metabolic disease

This mix of studies shows a practical interest in preventing complications and improving quality of life for people living with long-standing metabolic illness.